Table 2.
Oligonucleotide sequences used in this study
| Name | Sequence |
|---|---|
| AAF | 5′-GGCG(AAF)CC- |
| AF | 5′-GGCG(AF)CC- |
| C209 | 5′-ACAGA- |
| C209-ALII | 5′-ACA(AL)GA- |
| C209 with mismatch | 5′-ACACA− |
| -TCCCT-5′ | |
| C209-ALII with mismatch | 5′-ACA(AL)CA- |
| -TC C CT-5′ | |
| SI6 | 5′-CTAGG- |
| SI6-ALII | 5′-CTA(AL)GG- |
| SI6 with mismatch | 5′-CCACG- |
| -GCCCC-5′ | |
| SI6-ALII with mismatch | 5′-CCA(AL)CG- |
| -GC C CC-5′ |
AAF (dG-AAF), N-(deoxyguanosin-8-yl)-2-acetylaminofluorene; C209, codon 209; SI6, splice site, intron 6; AF (dG-AF), N-(deoxyguanosin-8-yl)-2-aminofluorene; ALII (dA-ALII), 7-(deoxyadenosin-N6-yl) aristolactam II (R = H). The modified residue is indicated in bold.